TURNING POINT THERAPEUTICS I's ticker is TPTX and the CUSIP is 90041T108. A total of 196 filers reported holding TURNING POINT THERAPEUTICS I in Q4 2020. The put-call ratio across all filers is 0.56 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $36,915,000 | +173.2% | 490,585 | -2.5% | 0.30% | +230.4% |
| Q1 2022 | $13,513,000 | -50.8% | 503,288 | -12.5% | 0.09% | -47.4% |
| Q4 2021 | $27,451,000 | -20.6% | 575,488 | +10.5% | 0.18% | -25.5% |
| Q3 2021 | $34,583,000 | -14.9% | 520,625 | 0.0% | 0.24% | -15.5% |
| Q2 2021 | $40,620,000 | -24.0% | 520,625 | +13.9% | 0.28% | -37.5% |
| Q1 2021 | $53,482,000 | -3.9% | 456,941 | -0.0% | 0.44% | +0.9% |
| Q4 2020 | $55,681,000 | +171.0% | 456,946 | +94.3% | 0.44% | +128.5% |
| Q3 2020 | $20,543,000 | +33.6% | 235,163 | -1.2% | 0.19% | +19.1% |
| Q2 2020 | $15,378,000 | +65.4% | 238,081 | +56.0% | 0.16% | +57.3% |
| Q1 2020 | $9,295,000 | -2.2% | 152,640 | +0.0% | 0.10% | +1.0% |
| Q4 2019 | $9,507,000 | +666.1% | 152,628 | +362.5% | 0.10% | +537.5% |
| Q3 2019 | $1,241,000 | – | 33,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Cormorant Asset Management, LP | 2,392,297 | $291,501,000 | 6.94% |
| Burrage Capital Management LLC | 72,484 | $8,832,000 | 6.73% |
| MPM BioImpact LLC | 617,372 | $75,226,000 | 6.50% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 113,541 | $13,816,000 | 3.77% |
| Orbimed Advisors | 2,745,327 | $334,518,000 | 2.93% |
| SECTORAL ASSET MANAGEMENT INC | 257,379 | $31,362,000 | 2.21% |
| Parkman Healthcare Partners LLC | 59,377 | $7,235,000 | 1.85% |
| Nicholas Investment Partners, LP | 183,676 | $22,381,000 | 1.73% |
| EMERALD ADVISERS, LLC | 357,038 | $43,505,000 | 1.44% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 336,173 | $40,963,000 | 1.42% |